Advyzon Investment Management LLC Buys New Shares in Colgate-Palmolive Company (NYSE:CL)

Key Points

• Advyzon Investment Management LLC acquired a new stake of 3,011 shares in Colgate-Palmolive, valued at approximately $282,000, during the first quarter of the year.
• Colgate-Palmolive reported an EPS of $0.92 for its most recent quarter, surpassing analyst expectations of $0.89, with revenue also exceeding estimates at $5.11 billion.
• The company announced a quarterly dividend of $0.52, reflecting an annualized dividend of $2.08 and a yield of 2.5%.

Advyzon Investment Management LLC bought a new stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,011 shares of the company's stock, valued at approximately $282,000.

Several other large investors also recently added to or reduced their stakes in CL. Brighton Jones LLC increased its stake in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after acquiring an additional 450 shares during the last quarter. Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth $36,000. Grantham Mayo Van Otterloo & Co. LLC increased its stake in shares of Colgate-Palmolive by 4.1% in the fourth quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 12,677 shares of the company's stock worth $1,152,000 after acquiring an additional 495 shares during the last quarter. Cerity Partners LLC increased its stake in shares of Colgate-Palmolive by 0.6% in the fourth quarter. Cerity Partners LLC now owns 217,237 shares of the company's stock worth $20,092,000 after acquiring an additional 1,398 shares during the last quarter. Finally, Invesco Ltd. increased its stake in shares of Colgate-Palmolive by 2.7% in the fourth quarter. Invesco Ltd. now owns 6,537,918 shares of the company's stock worth $594,362,000 after acquiring an additional 169,140 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL stock traded down $0.00 during mid-day trading on Friday, reaching $84.71. 4,133,894 shares of the stock traded hands, compared to its average volume of 4,850,591. The company has a quick ratio of 0.28, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 52 week low of $82.40 and a 52 week high of $109.30. The business has a 50-day moving average of $88.76 and a two-hundred day moving average of $90.15. The firm has a market capitalization of $68.46 billion, a PE ratio of 23.79, a P/E/G ratio of 4.41 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. During the same period in the prior year, the company earned $0.91 earnings per share. The business's quarterly revenue was up 1.0% compared to the same quarter last year. As a group, equities analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio is 58.43%.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Barclays upped their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 15th. Citigroup dropped their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Finally, UBS Group lowered their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.